Provider
Interleukin-31 (IL-31) Inhibitor - Commercial - Opens in a new window
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Program effective Date: Apr 01, 2025
Program effective Date: Apr 01, 2025
Program effective Date: Apr 01, 2025
Program effective Date: Apr 01, 2025
Program effective Date: Apr 01, 2025
Program effective Date: Apr 01, 2025
Program effective Date: Apr 01, 2025
Coverage Exception
Program effective Date: Apr 01, 2025
Coverage Exception
Program effective Date: Apr 01, 2025